Study identifier:9188US/0011
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
The Effectiveness and Safety of Oral ICI 204,219 in the Treatment of Acute Seasonal Allergic Rhinitis: A Dose-Ranging Study (9188US/0011:0001)
-
-
-
-
-
-
-
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2022 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|